JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: XE991 diHCl (LS190926) is a novel, potent and selective blocker of KCNQ (Kv7) voltage-gated potassium channels. XE991 blocks KCNQ2+3/M-currents (IC50 = 0.6-0.98 uM) and KCNQ1 homomeric channels (IC50 = 0.75 uM) but is less potent against KCNQ1/minK channels (IC50 = 11.1 uM).
References:
1. WangHS, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecularcorrelates of the M-channel. Science. 1998 Dec 4; 282(5395):1890-3.
2. ZaczekR, et al. Two new potent neurotransmitter release enhancers, 10, 10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and10, 10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison tolinopirdine. J Pharmacol Exp Ther. 1998 May; 285(2):724-30.
3. Greene DL, Kang S, Hoshi N. XE991 and Linopirdine are state-dependent inhibitors for Kv7/KCNQ channels that favor activated single subunits. J Pharmacol Exp Ther. 2017 May 8. pii: jpet.117.241679.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!